Arca Biopharma | ABIO - Market Capitalization


Arca Biopharma reported $608M in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alterity Therapeutics Limited AUD 11M 5M Jun/2023
Amgen USD 176.25B 24.32B Dec/2025
Arca Biopharma USD 600M 867M Mar/2026
Biogen USD 25.82B 5.28B Dec/2025
Brainstorm Cell Therapeutics USD 43M 35M Mar/2026
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Capricor Therapeutics USD 966M 690M Mar/2026
Cipla INR 1.22T 6.47B Dec/2025
Clal Biotechnology ILS 43.45M 8.92M Mar/2026
Compugen USD 620.58M 475.91M Mar/2026
CSL USD 71.32B 15.44B Mar/2026
Cytokinetics USD 7.77B 1.19B Dec/2025
Daiichi Sankyo JPY 6.34T 62.51B Dec/2025
Gilead Sciences USD 152.28B 14.55B Dec/2025
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
Grifols EUR 2.02B 4.34B Mar/2026
Laboratory Of America USD 20.8B 3.03B Dec/2025
Myriad Genetics USD 417M 158M Mar/2026
Otsuka Holdings JPY 5.97T 1.15T Mar/2026
Pfizer USD 153.96B 12.4B Mar/2026
United Therapeutics USD 20.98B 2.02B Dec/2025